Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension
EARLIER
2 other identifiers
observational
500
1 country
1
Brief Summary
Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2017
CompletedFirst Posted
Study publicly available on registry
January 3, 2018
CompletedStudy Start
First participant enrolled
May 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2035
May 19, 2022
May 1, 2022
11.7 years
December 22, 2017
May 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement PetCO2
Measurement PetCO2 by capnography at rest after or before a right heart catheterization, comparison of the parameter between patients with and without
At baseline
Secondary Outcomes (1)
Establishing a cut-off
At baseline
Study Arms (1)
Suspicion of pulmonary hypertension
At Patients with suspicion of pulmonary hypertension, which get a right heart catheterization, in the context of the study the exhaled air, precious the endtidal carbon dioxide (CO2), before or after the right heart catheterization will be measured through capnography.
Interventions
Measuring of the exhaled air, especially endtidal co2, through capnography.
Eligibility Criteria
Patients of a tertiary referral center retro- and prospective part of the study. Afterwards in a next prospective study part patients in ambulant setting.
You may qualify if:
- Age \> 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart catheterization
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinic Giessen and Marburg
Giessen, Hesse, 35392, Germany
Related Publications (1)
Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest. 2011 Nov;140(5):1267-1273. doi: 10.1378/chest.11-0155. Epub 2011 May 26.
PMID: 21622547BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henning Gall, MD, PhD
University Clinic Giessen and Marburg - Campus Giessen
- STUDY DIRECTOR
Werner Seeger, Prof.
University Clinic Giessen and Marburg
- STUDY DIRECTOR
Ardeschir Ghofrani, Prof.
University Clinic Giessen and Marburg
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Chair: Ghofrani H. Ardeschir, Prof. Dr. University of Giessen
Study Record Dates
First Submitted
December 22, 2017
First Posted
January 3, 2018
Study Start
May 2, 2018
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2035
Last Updated
May 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share